Company profile: Lindy Biosciences
1.1 - Company Overview
Company description
- Provider of protein therapeutic formulation technologies, including Microglassificationβ’ to create solid amorphous microbeads for stable long-term storage and subcutaneous delivery; high-concentration biologic formulations that reduce viscosity and increase stability for subcutaneous dosing of monoclonal antibodies; and MG Suspensions offering a subcutaneous alternative to intravenous infusions.
Products and services
- Microglassificationβ’: A proprietary process that removes water from protein solutions to produce solid, spherical, amorphous microbeads (particle-based), enabling stable long-term storage and subcutaneous delivery of biologics
- MG Suspensions: Suspensions of solid particles created through Microglassificationβ’ (microbead-based) that replace intravenous infusions for antibody therapeutics by permitting subcutaneous administration while maintaining formulation integrity
- High-Concentration Biologics: Formulations engineered to reduce viscosity and increase stability (subcutaneous-optimized), enabling high doses of biologics, particularly monoclonal antibodies, to be administered via subcutaneous injection
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Lindy Biosciences
HealthMode
HQ: United States
Website
- Description: Provider of AI-enabled digital measurement methods that increase the precision and speed of clinical research and improve healthcare, driving progression to next-generation clinical trials through the development and delivery of digital measurements for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full HealthMode company profile β
Bio-Optronics
HQ: United States
Website
- Description: Provider of healthcare information technology software focused on workflow optimization for healthcare organizations, offering Clinical Conductor CTMS with tools for patient recruitment, budgeting, billing, reporting, and participant engagement, integrated with other platforms for enhanced data quality and compliance; CCText two-way messaging for decentralized trial communications; and CCPay real-time participant payment reimbursements with analytics and caregiver support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Bio-Optronics company profile β
MDDX
HQ: United States
Website
- Description: Provider of technologies and affordable research applications that unlock insights your data did not reveal, improving efficiency and scalability of multicenter trials; offering nearly a dozen tools used by thousands of researchers in dozens of global research trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full MDDX company profile β
NiKang Therapeutics
HQ: United States
Website
- Description: Provider of small-molecule oncology therapeutics, developing NKT2152, a HIF2Ξ± inhibitor in Phase 1/2 for clear cell renal cell carcinoma and other solid tumors; NKT3447, a reversible ATP-competitive CDK2 inhibitor in Phase 1 for solid tumors; KRAS G12D mutation inhibitors; and a SHP2 inhibitor being clinically evaluated by Erasca.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full NiKang Therapeutics company profile β
eClinical Insights
HQ: United States
Website
- Description: Provider of cloud-based clinical software products offering a business analytic engine, data visualization application, and trial management services to organizations to optimize the performance of clinical trials, project teams, clinical systems, and service providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full eClinical Insights company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Lindy Biosciences
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lindy Biosciences
2.2 - Growth funds investing in similar companies to Lindy Biosciences
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Lindy Biosciences
4.2 - Public trading comparable groups for Lindy Biosciences
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β